XENBYVE Trademark

Trademark Overview


On Wednesday, February 27, 2019, a trademark application was filed for XENBYVE with the United States Patent and Trademark Office. The USPTO has given the XENBYVE trademark a serial number of 88318048. The federal status of this trademark filing is REGISTERED as of Tuesday, October 8, 2019. This trademark is owned by Samsung Bioepis Co., Ltd.. The XENBYVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis
xenbyve

General Information


Serial Number88318048
Word MarkXENBYVE
Filing DateWednesday, February 27, 2019
Status700 - REGISTERED
Status DateTuesday, October 8, 2019
Registration Number5878488
Registration DateTuesday, October 8, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 18, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSamsung Bioepis Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIncheon, 21987
KR

Party NameSamsung Bioepis Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIncheon, 21987
KR

Party NameSamsung Bioepis Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIncheon, 21987
KR

Trademark Events


Event DateEvent Description
Tuesday, October 8, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 13, 2019ASSIGNED TO LIE
Friday, June 7, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 29, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, March 29, 2019LETTER OF SUSPENSION E-MAILED
Friday, March 29, 2019SUSPENSION LETTER WRITTEN
Friday, March 29, 2019EXAMINER'S AMENDMENT ENTERED
Friday, March 29, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 29, 2019EXAMINERS AMENDMENT E-MAILED
Friday, March 29, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 26, 2019ASSIGNED TO EXAMINER
Monday, March 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 2, 2019NEW APPLICATION ENTERED IN TRAM